Community Member
a day agoMy oncologist suggested Zejula to me as a maintenance drug. Is anyone familiar with it and how are the side effects?
Community Member
a day agoZejula (niraparib) is a PARP inhibitor commonly used as maintenance therapy for ovarian cancer, and many people in this community have experience with it. Side effects can vary from person to person, but connecting with others who have been on this medication can provide valuable insights into what to expect and how to manage any challenges that might come up. Hopefully some community members will share their experiences to help guide your decision-making process with your care team.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.